{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:55:50Z","timestamp":1787241350311,"version":"build-2736575974"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Macao Science and Technology Development Fund","doi-asserted-by":"publisher","award":["0060\/2018\/A2"],"award-info":[{"award-number":["0060\/2018\/A2"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Macao Science and Technology Development Fund","doi-asserted-by":"publisher","award":["0036\/2018\/AFJ"],"award-info":[{"award-number":["0036\/2018\/AFJ"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foshan Medicine Dengfeng Project","award":["2019-2021"],"award-info":[{"award-number":["2019-2021"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.phymed.2020.153208","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T01:08:05Z","timestamp":1584493685000},"page":"153208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease"],"prefix":"10.1016","volume":"70","author":[{"given":"Bin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Hong","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka In","family":"U","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-2543","authenticated-orcid":false,"given":"Wen-Luan Wendy","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2951-8108","authenticated-orcid":false,"given":"Vincent Kam-Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8926-3960","authenticated-orcid":false,"given":"Betty Yuen-Kwan","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2020.153208_bib0001","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1139\/cjpp-2014-0251","article-title":"Resveratrol protects against experimental induced Reye\u2019s syndrome by prohibition of oxidative stress and restoration of complex I activity","volume":"92","author":"Abdin","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phymed.2020.153208_bib0002","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","article-title":"Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)","volume":"47","author":"Ayusawa","year":"2005","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.phymed.2020.153208_bib0003","article-title":"Therapeutic effect of integrated traditional Chinese and Western medicine on Kawasaki disease","volume":"18","author":"Baoshen","year":"2018","journal-title":"World Latest Med. Inf."},{"key":"10.1016\/j.phymed.2020.153208_bib0004","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM199905063401801","article-title":"Reye\u2019s syndrome in the United States from 1981 through 1997","volume":"340","author":"Belay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0005","doi-asserted-by":"crossref","first-page":"E489","DOI":"10.1542\/peds.2010-1218","article-title":"Recurrent fever syndromes in patients after recovery from Kawasaki syndrome","volume":"127","author":"Broderick","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.phymed.2020.153208_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000319","article-title":"A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease","volume":"5","author":"Burgner","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0007","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2020.153208_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.106.2.e27","article-title":"Kawasaki disease: a brief history","volume":"106","author":"Burns","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.phymed.2020.153208_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002822","article-title":"Chapter 11: Genome-wide association studies","volume":"8","author":"Bush","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.phymed.2020.153208_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.micpath.2017.12.027","article-title":"Cryptotanshinone inhibits prostaglandin E2 production and COX-2 expression via suppression of TLR4\/NF-kappa B signaling pathway in LPS-stimulated Caco-2 cells","volume":"116","author":"Cao","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.phymed.2020.153208_bib0011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jfma.2013.12.008","article-title":"Viral infections associated with Kawasaki disease","volume":"113","author":"Chang","year":"2014","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.phymed.2020.153208_bib0012","series-title":"Reye Syndrome, StatPearls","author":"Chapman","year":"2020"},{"key":"10.1016\/j.phymed.2020.153208_bib0013","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1017\/S1047951114000626","article-title":"Absence of association of FCGR2A gene polymorphism rs1801274 with Kawasaki disease in Greek patients","volume":"25","author":"Chatzikyriakidou","year":"2015","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.phymed.2020.153208_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/864597","article-title":"Qing re liang xue decoction alleviates hypercoagulability in Kawasaki disease","author":"Chen","year":"2015","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0015","series-title":"Reye (Ray's) Syndrome: a Problem Everyone Should Remember","first-page":"110","author":"Chornomydz","year":"2017"},{"key":"10.1016\/j.phymed.2020.153208_bib0016","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.111.082107","article-title":"Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia","volume":"125","author":"Daniels","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2020.153208_bib0017","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/heartjnl-2017-311774","article-title":"Management of Kawasaki disease in adults","volume":"103","author":"Denby","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.phymed.2020.153208_bib0018","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-014-0423-x","article-title":"Kawasaki Disease: pathophysiology, clinical manifestations, and management","volume":"16","author":"Dimitriades","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.phymed.2020.153208_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700890","article-title":"Epigallocatechin gallate reduces amyloid beta-induced neurotoxicity via inhibiting endoplasmic reticulum stress-mediated apoptosis","volume":"62","author":"Du","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phymed.2020.153208_bib0020","first-page":"226","article-title":"Genome-wide association study of Parkinson\u2019s disease in East Asians","volume":"26","author":"Foo","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0021","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00213-019-05210-6","article-title":"Tetramethylpyrazine ameliorates depression by inhibiting TLR4-NLRP3 inflammasome signal pathway in mice","volume":"236","author":"Fu","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phymed.2020.153208_bib0022","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12969-017-0169-x","article-title":"Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: a case report","volume":"15","author":"Fukuda","year":"2017","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.phymed.2020.153208_bib0023","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/ped.13614","article-title":"Kawasaki disease shock syndrome: unique and severe subtype of Kawasaki disease","volume":"60","author":"Gamez\u2010Gonzalez","year":"2018","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.phymed.2020.153208_bib0024","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3346\/jkms.2016.31.9.1445","article-title":"Epidemiologic study on Kawasaki Disease in Korea, 2007\u20132014: based on health insurance review & assessment service claims","volume":"31","author":"Ha","year":"2016","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.phymed.2020.153208_bib0025","doi-asserted-by":"crossref","first-page":"e7583","DOI":"10.1097\/MD.0000000000007583","article-title":"Correlation between elevated platelet count and immunoglobulin levels in the early convalescent stage of Kawasaki disease","volume":"96","author":"Han","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.phymed.2020.153208_bib0026","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cei.12832","article-title":"Kawasaki disease: a matter of innate immunity","volume":"186","author":"Hara","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.phymed.2020.153208_bib0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.174.1.41","article-title":"Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis","volume":"174","author":"Hill","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2020.153208_bib0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1442-200X.2011.03487.x","article-title":"Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease","volume":"54","author":"Hokosaki","year":"2012","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.phymed.2020.153208_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.phymed.2020.153208_bib0030","series-title":"Anti-Inflammatory Effect of Resveratrol in Human Coronary Arterial Endothelial Cells Via Induction of Autophagy: Implication for the Treatment of Kawasaki Disease","author":"Huang","year":"2017"},{"key":"10.1016\/j.phymed.2020.153208_bib0031","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/adc.2010.184101","article-title":"Assessment of intravenous immunoglobulin non-responders in Kawasaki disease","volume":"96","author":"Hwang","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.phymed.2020.153208_bib0032","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/cid\/cis807","article-title":"Human adenovirus infection in Kawasaki disease: a confounding bystander?","volume":"56","author":"Jaggi","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.phymed.2020.153208_bib138","article-title":"Summary and Abstracts of the Seventh International Kawasaki Disease Symposium: December 4\u20137, 2001, Hakone, Japan","volume":"53","author":"Jane","year":"2003","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.phymed.2020.153208_bib0033","series-title":"The 24th National Survey Results of Kawasaki Disease in Japan","author":"Japan","year":"2017"},{"key":"10.1016\/j.phymed.2020.153208_bib0034","first-page":"196","article-title":"Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease","volume":"15","author":"Ji","year":"2013","journal-title":"Chin. J. Contemp. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2249.2010.04236.x","article-title":"The T helper type 17\/regulatory T cell imbalance in patients with acute Kawasaki disease","volume":"162","author":"Jia","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.phymed.2020.153208_bib0036","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/INF.0b013e3181dba70b","article-title":"Concomitant respiratory viral infections in children with Kawasaki disease","volume":"29","author":"Jordan-Villegas","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0037","article-title":"A presumed etiology of Kawasaki disease based on epidemiological comparison with infectious or immune-mediated diseases","volume":"7","author":"Jung-Woo","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0038","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1289\/EHP137","article-title":"Ambient air pollutant exposures and hospitalization for Kawasaki disease in Taiwan: a case-crossover study (2000\u20132010)","volume":"125","author":"Jung","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.phymed.2020.153208_bib0039","first-page":"1","article-title":"Pediatric acute febrile mucocutaneous lymph node syndrome with characteristic desquamation of fingers and toes: my clinical observation of fifty cases","volume":"21","author":"Kawasaki","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.phymed.2020.153208_bib141","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1542\/peds.54.3.271","article-title":"A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in Japan","volume":"54","author":"Kawasaki","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.phymed.2020.153208_bib0040","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ng.981","article-title":"Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease","volume":"43","author":"Khor","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0041","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12969-017-0192-y","article-title":"Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea","volume":"15","author":"Kil","year":"2017","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.phymed.2020.153208_bib0042","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/INF.0000000000001474","article-title":"Epidemiology and clinical features of Kawasaki disease in South Korea, 2012\u20132014","volume":"36","author":"Kim","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0043","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00246-012-0289-5","article-title":"Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children","volume":"33","author":"Kim","year":"2012","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.phymed.2020.153208_bib0044","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00246-014-1032-1","article-title":"Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease","volume":"36","author":"Kim","year":"2015","journal-title":"Pediatr. Cardiol."},{"issue":"6","key":"10.1016\/j.phymed.2020.153208_bib140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3349\/ymj.2006.47.6.759","article-title":"Kawasaki disease","volume":"47","author":"Kim","year":"2006","journal-title":"YONSEI MED J"},{"key":"10.1016\/j.phymed.2020.153208_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00439-010-0937-x","article-title":"A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease","volume":"129","author":"Kim","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0046","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00246-011-0143-1","article-title":"Assessment of risk factors for Korean children with Kawasaki disease","volume":"33","author":"Kim","year":"2012","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.phymed.2020.153208_bib0047","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/jhg.2013.43","article-title":"Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis","volume":"58","author":"Kim","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0048","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/jhg.2017.87","article-title":"A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease","volume":"62","author":"Kim","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0049","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3349\/ymj.2016.57.1.15","article-title":"Recent advances in Kawasaki disease","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0050","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/art.38976","article-title":"Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array","volume":"67","author":"Kuo","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.phymed.2020.153208_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143056","article-title":"Gene-gene associations with the susceptibility of Kawasaki disease and coronary artery lesions","volume":"10","author":"Kuo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2020.153208_bib0052","doi-asserted-by":"crossref","unstructured":"Kuo, H.C., Chao, M.C., Hsu, Y.W., Lin, Y.C., Huang, Y.H., Yu, H.R., Hou, M.F., Liang, C.D., Yang, K.D., Chang, W.C., Wang, C.L., 2012. CD40 gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population. Sci. World J.","DOI":"10.1100\/2012\/520865"},{"key":"10.1016\/j.phymed.2020.153208_bib0053","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-3038.2007.00516.x","article-title":"The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease","volume":"18","author":"Kuo","year":"2007","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.phymed.2020.153208_bib0054","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2188\/jea.JE20140128","article-title":"Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan","volume":"25","author":"Kuwabara","year":"2015","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.phymed.2020.153208_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184248","article-title":"Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease","volume":"12","author":"Kwon","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2020.153208_bib0056","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbi.2016.12.012","article-title":"Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia","volume":"61","author":"Lan","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phymed.2020.153208_bib0057","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4070\/kcj.2015.45.6.443","article-title":"Consortium-based genetic studies of Kawasaki disease in Korea: Korean Kawasaki disease genetics consortium","volume":"45","author":"Lee","year":"2015","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2006.12.051","article-title":"Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora","author":"Lee","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.phymed.2020.153208_bib0059","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3349\/ymj.2012.53.2.262","article-title":"Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a \u201cprotein homeostasis system\u201d","volume":"53","author":"Lee","year":"2012","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3345\/kjp.2016.59.4.174","article-title":"Usefulness of anterior uveitis as an additional tool for diagnosing incomplete Kawasaki disease","volume":"59","author":"Lee","year":"2016","journal-title":"Korean J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0061","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4070\/kcj.2015.45.6.516","article-title":"T-Helper cytokine profiles in patients with Kawasaki disease","volume":"45","author":"Lee","year":"2015","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0062","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3349\/ymj.2008.49.5.714","article-title":"Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease","volume":"49","author":"Lee","year":"2008","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0063","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2227","article-title":"Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis","volume":"44","author":"Lee","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0064","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lfs.2018.07.053","article-title":"Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4\/NF-kappa B signaling pathway","volume":"209","author":"Leng","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2020.153208_bib0065","article-title":"Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2020.153208_bib0066","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.chemosphere.2017.08.054","article-title":"Ambient air pollution, temperature and Kawasaki disease in Shanghai, China","volume":"186","author":"Lin","year":"2017","journal-title":"Chemosphere"},{"key":"10.1016\/j.phymed.2020.153208_bib0067","first-page":"1890","article-title":"Therapeutic effect of traditional Chinese medicine combined with gamma globulin and aspirin on Kawasaki disease","volume":"25","author":"Linlin","year":"2016","journal-title":"Modern J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0068","first-page":"138","article-title":"Clinical observation on 50 cases of Kawasaki disease treated by integrative Chinese and western medicine","volume":"34","author":"Linlin","year":"2016","journal-title":"J. Sichuan Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0069","article-title":"Clinical observation on treatment of Kawasaki disease with Jiedu Huayu decoction combined with gamma globulin","volume":"180","author":"Liu","year":"2017","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0070","doi-asserted-by":"crossref","DOI":"10.29219\/fnr.v63.1516","article-title":"Suppressive effect of glycyrrhizic acid against lipopolysaccharide-induced neuroinflammation and cognitive impairment in C57 mice via toll-like receptor 4 signaling pathway","volume":"63","author":"Liu","year":"2019","journal-title":"Food Nutr. Res."},{"key":"10.1016\/j.phymed.2020.153208_bib0071","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pedneo.2013.07.010","article-title":"Epidemiological features of Kawasaki disease in Taiwan, 1976\u20132007: results of five nationwide questionnaire hospital surveys","volume":"55","author":"Lue","year":"2014","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.phymed.2020.153208_bib0072","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1749-8546-5-9","article-title":"Clinical observation of ligustrazine in the treatment of Kawasaki disease","volume":"19","author":"Luo","year":"2010","journal-title":"Chin. Natl. Folk Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0073","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/989307","article-title":"Understanding the pathogenesis of Kawasaki disease by network and pathway analysis","author":"Lv","year":"2013","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0074","doi-asserted-by":"crossref","unstructured":"Maconochie, I.K., 2004. Kawasaki disease. Archives of disease in childhood - Education & practice edition 89, ep3-ep8.","DOI":"10.1136\/adc.2004.053728"},{"key":"10.1016\/j.phymed.2020.153208_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2019.109371","article-title":"Cannabinoids \u03949-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-\u03baB signaling","volume":"133","author":"Majdi","year":"2019","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.phymed.2020.153208_bib0076","doi-asserted-by":"crossref","first-page":"E927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2020.153208_bib0077","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.intimp.2009.09.005","article-title":"Preventive and curative glycoside kaempferol treatments attenuate the TH2-driven allergic airway disease","volume":"9","author":"Medeiros","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2020.153208_bib0078","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2352-4642(18)30293-1","article-title":"Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study","volume":"2","author":"Miyata","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.phymed.2020.153208_bib0079","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3345\/kjp.2016.59.4.178","article-title":"Prediction of nonresponsiveness to medium-dose intravenous immunoglobulin (1\u00a0g\/kg) treatment: an effective and safe schedule of acute treatment for Kawasaki disease","volume":"59","author":"Moon","year":"2016","journal-title":"Korean J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0080","first-page":"960","article-title":"An autopsied case of Reye syndrome in progress of MCLS","volume":"43","author":"Nejihashi","year":"1980","journal-title":"Shonika Shinryo"},{"key":"10.1016\/j.phymed.2020.153208_bib0081","first-page":"9","article-title":"Treatment of 18 Cases of Kawasaki Disease with Coronary Aneurysm with Ligustrazine","volume":"18","author":"Neng","year":"1996","journal-title":"Hubei J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0082","first-page":"2747","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease \u2013 a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young","volume":"110","author":"Newburger","year":"2004","journal-title":"Am. Heart Assoc. Circul."},{"key":"10.1016\/j.phymed.2020.153208_bib0083","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/pr.2014.92","article-title":"Transcriptional regulation by infliximab therapy in kawasaki disease patients with immunoglobulin resistance","volume":"76","author":"Ogihara","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.phymed.2020.153208_bib0084","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00246-007-9146-3","article-title":"Polymorphisms of human leukocyte antigen genes in Korean children with Kawasaki disease","volume":"29","author":"Oh","year":"2008","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.phymed.2020.153208_bib139","first-page":"663","article-title":"Management of Kawasaki Syndrome: A Consensus Statement Prepared by North American Participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan","volume":"8","author":"O\u2019Loughlin","year":"1989","journal-title":"PIDJ."},{"key":"10.1016\/j.phymed.2020.153208_bib0085","doi-asserted-by":"crossref","first-page":"46R","DOI":"10.1203\/PDR.0b013e31819dba60","article-title":"Molecular genetics of Kawasaki disease","volume":"65","author":"Onouchi","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.phymed.2020.153208_bib0086","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2177\/jsci.33.73","article-title":"Identification of susceptibility genes for Kawasaki disease","volume":"33","author":"Onouchi","year":"2010","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.phymed.2020.153208_bib0087","doi-asserted-by":"crossref","unstructured":"Onouchi, Y., 2012. Genetics of Kawasaki disease \u2013 what we know and don't know, Japan, p. 1581.","DOI":"10.1253\/circj.CJ-12-0568"},{"key":"10.1016\/j.phymed.2020.153208_bib0088","first-page":"1","article-title":"Identification of susceptibility genes for Kawasaki disease","volume":"91","author":"Onouchi","year":"2015","journal-title":"Chiba Med. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0089","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/hmg\/ddq176","article-title":"Common variants in CASP3 confer susceptibility to Kawasaki disease","volume":"19","author":"Onouchi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/tpj.2011.45","article-title":"ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease","volume":"13","author":"Onouchi","year":"2011","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0091","article-title":"Plasma clusterin concentrations may predict resistance to intravenous immunoglobulin in patients with Kawasaki disease","volume":"5","author":"Ou-Yang","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.phymed.2020.153208_bib0092","series-title":"Periodic and Non-Periodic Fevers","first-page":"45","article-title":"Kawasaki Disease","author":"Pilania","year":"2020"},{"key":"10.1016\/j.phymed.2020.153208_bib0093","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/pr.2012.168","article-title":"Kawasaki disease and soy: potential role for isoflavone interaction with Fc gamma receptors","volume":"73","author":"Portman","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.phymed.2020.153208_bib0094","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.nutres.2016.04.002","article-title":"Soy isoflavone intake is associated with risk of Kawasaki disease","volume":"36","author":"Portman","year":"2016","journal-title":"Nutr. Res."},{"key":"10.1016\/j.phymed.2020.153208_bib0095","article-title":"Meta-analyses of the associations of genome-wide association study-linked gene loci with Kawasaki disease","volume":"571","author":"Qian","year":"2013","journal-title":"Chin. J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0096","first-page":"123","article-title":"Clinical effect of integrated traditional Chinese and western medicine treatment on Kawasaki disease","author":"Qin","year":"2017","journal-title":"Clin. Res. Pract."},{"key":"10.1016\/j.phymed.2020.153208_bib0097","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/0748233714554941","article-title":"Protective effect of crocin against apoptosis induced by subchronic exposure of the rat vascular system to diazinon","volume":"32","author":"Razavi","year":"2016","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.phymed.2020.153208_bib0098","first-page":"870","article-title":"Reye syndrome and juvenile rheumatoid-arthritis in Michigan","volume":"139","author":"Remington","year":"1985","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.phymed.2020.153208_bib0099","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-5-41","article-title":"Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression","volume":"5","author":"Rezai-Zadeh","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phymed.2020.153208_bib0100","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00202","article-title":"A presumed etiology of Kawasaki disease based on epidemiological comparison with infectious or immune-mediated diseases","volume":"7","author":"Rhim","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0101","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/INF.0000000000000123","article-title":"Changes in Kawasaki disease during 2 decades at a single institution in Daejeon, Korea","volume":"33","author":"Rhim","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0102","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.1400380111","article-title":"Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan","volume":"111","author":"Rodo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. US A"},{"key":"10.1016\/j.phymed.2020.153208_bib0103","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.1093\/jpids\/pix025","article-title":"Allograft inflammatory factor-1 links T-Cell activation, interferon response, and macrophage activation in chronic Kawasaki disease arteritis","volume":"6","author":"Rowley","year":"2017","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"10.1016\/j.phymed.2020.153208_bib0104","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrmicro1853","article-title":"Opinion \u2013 searching for the cause of Kawasaki disease \u2013 cytoplasmic inclusion bodies provide new insight","volume":"6","author":"Rowley","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.phymed.2020.153208_bib0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/CMR.11.3.405","article-title":"Kawasaki syndrome","volume":"11","author":"Rowley","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.phymed.2020.153208_bib0106","doi-asserted-by":"crossref","first-page":"E397","DOI":"10.1097\/INF.0b013e31829dd45e","article-title":"Clinical Characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China","volume":"32","author":"Ruan","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0107","article-title":"Effect of heat-clearing and blood-activating herbs on platelet parameters in children with Kawasaki disease","volume":"492","author":"Ruo-Sha","year":"2008","journal-title":"J. Guangzhou Univ. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0108","first-page":"365","article-title":"Diagnosis and management of kawasaki disease","volume":"91","author":"Saguil","year":"2015","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.phymed.2020.153208_bib0109","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/1756-185X.12082","article-title":"Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients","volume":"16","author":"Sato","year":"2013","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.phymed.2020.153208_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3345\/kjp.2018.61.5.160","article-title":"Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment","volume":"61","author":"Seo","year":"2018","journal-title":"Korean J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0111","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","article-title":"Kawasaki disease: insights into pathogenesis and approaches to treatment","volume":"11","author":"Shulman","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phymed.2020.153208_bib0112","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpeds.2008.01.001","article-title":"Prenatal cocaine exposure: drug and environmental effects at 9 years","volume":"153","author":"Singer","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0113","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/archdischild-2014-307536","article-title":"The epidemiology of Kawasaki disease: a global update","volume":"100","author":"Singh","year":"2015","journal-title":"Arch. Disease Child."},{"key":"10.1016\/j.phymed.2020.153208_bib0114","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance","volume":"158","author":"Sleeper","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0115","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jpeds.2010.10.012","article-title":"Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study","volume":"158","author":"Son","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0116","series-title":"Infliximab Treatment for Refractory Kawasaki Disease in Korean Children","author":"Song","year":"2010"},{"key":"10.1016\/j.phymed.2020.153208_bib0117","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.4049\/jimmunol.1801593","article-title":"TNF and IL-1 play essential but temporally distinct roles in driving cardiac inflammation in a murine model of Kawasaki disease","volume":"202","author":"Stock","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2020.153208_bib0118","first-page":"185","article-title":"Case report Reye\u2019s syndrome arising from the treatment of Kawasaki disease","volume":"23","author":"Su","year":"2018","journal-title":"HK J. Paediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0119","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3476(97)70038-6","article-title":"Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose","volume":"131","author":"Terai","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0120","first-page":"49","article-title":"Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease","volume":"46","author":"Wang","year":"2008","journal-title":"Chin. J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0121","first-page":"818","article-title":"Change of MyD88-independent signal transduction of Toll-like receptor 4 in immunological pathogenesis of Kawasaki disease","volume":"45","author":"Wang","year":"2007","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.phymed.2020.153208_bib0122","article-title":"Pay attention to the treatment of Chinese medicine in the acute phase of Kawasaki disease","volume":"131","author":"Wang","year":"2002","journal-title":"Modern J. Integr. Tradit. Chin. West. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0123","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3390\/molecules24101964","article-title":"Zerumbone protects against carbon tetrachloride (CCl4)-induced acute liver injury in mice via inhibiting oxidative stress and the inflammatory response: Involving the TLR4\/NF-\u03baB\/COX-2 pathway","volume":"24","author":"Wang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2020.153208_bib0124","article-title":"Treatment of 32 cases of Kawasaki disease with Baihu decoction","volume":"1458","author":"Wang","year":"2011","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.37815","article-title":"Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1\/Th2 cytokine profiles in patients with Kawasaki disease","volume":"65","author":"Wang","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phymed.2020.153208_bib0126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1754.2005.00617.x","article-title":"Reye\u2019s syndrome developing in an infant on treatment of Kawasaki syndrome","volume":"41","author":"Wei","year":"2005","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.phymed.2020.153208_bib0127","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between Parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.phymed.2020.153208_bib0128","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1074\/jbc.M511759200","article-title":"Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3","volume":"281","author":"Wu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2020.153208_bib0129","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.lfs.2007.08.040","article-title":"Emodin-mediated protection from acute myocardial infarction via inhibition of inflammation and apoptosis in local ischemic myocardium","volume":"81","author":"Wu","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2020.153208_bib0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3892\/etm.2011.404","article-title":"Dan-Shen-Yin protects the heart against inflammation and oxidative stress induced by acute ischemic myocardial injury in rats","volume":"3","author":"Yan","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0131","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00439-013-1279-2","article-title":"Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese","volume":"132","author":"Yan","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.phymed.2020.153208_bib0132","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5152\/balkanmedj.2013.7963","article-title":"Triptolide as an alternative to IVIG therapy for Kawasaki disease in a mouse model","volume":"30","author":"Yan","year":"2013","journal-title":"Balk. Med. J."},{"key":"10.1016\/j.phymed.2020.153208_bib0133","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00246-012-0223-x","article-title":"Single-nucleotide polymorphism rs2290692 in the 3\u2032UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population","volume":"33","author":"Yang","year":"2012","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.phymed.2020.153208_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.06.061","article-title":"Kawasaki disease and exposure to fine particulate air pollution","volume":"177","author":"Zeft","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0135","article-title":"Effects of Tanshinone \u2161_A for adjuvant treatment of Kawasaki disease","volume":"21","author":"Zhang","year":"2011","journal-title":"J. Appl. Clin. Pediatr."},{"key":"10.1016\/j.phymed.2020.153208_bib0136","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11655-015-2298-8","article-title":"Protective effects of Xiongshao Capsule on anti-inflammatory function of high-density lipoprotein in an atherosclerosis rabbit model","volume":"23","author":"Zhang","year":"2017","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phymed.2020.153208_bib0137","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00455","article-title":"Curcumin suppressed activation of dendritic cells via JAK\/STAT\/SOCS signal in mice with experimental colitis","volume":"7","author":"Zhao","year":"2016","journal-title":"Front. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711320300416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711320300416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:22:09Z","timestamp":1760552529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711320300416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":141,"alternative-id":["S0944711320300416"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2020.153208","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2020.153208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153208"}}